Cite
APA Citation
Schiff, M., Combe, B., Dörner, T., Kremer, J. M., Huizinga, T. W., Veenhuizen, M., Gill, A., Komocsar, W., Berclaz, P., Ortmann, R., & Lee, C. (2015). efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study. RMD open, 1(1), . http://access.bl.uk/ark:/81055/vdc_100137793482.0x000003